Vimarsana
Biggest News Aggregation in the World

Page 49 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

Ruxolitinib Response in Teens, Adults With Vitiligo Compared - Vimarsana News

Ruxolitinib Response in Teens, Adults With Vitiligo Compared

Pooled data from the phase 3 TRuE-V1 and TRuE-V2 studies were used to evaluate responses in a subset of adolescents treated with the topical JAK inhibitor for vitiligo.

Atacama's Altiplano Sets 'Incredible' Solar Irradiance World Record - Vimarsana News

Atacama's Altiplano Sets 'Incredible' Solar Irradiance World Record

Chile's Atacama Desert boasts the planet's hottest spot, setting world records for solar luminosity, but experts warn of extreme radiation risks. 24.07.2023, Sputnik International

Nonstimulants: A Better Option for ADHD? - Vimarsana News

Nonstimulants: A Better Option for ADHD?

Children and adults with ADHD show greater improvement in symptoms with viloxazine extended release compared with treatment with atomoxetine, new research suggests.

Pneumococcal Vaccine Label Adds Injection-Site Risk - Vimarsana News

Pneumococcal Vaccine Label Adds Injection-Site Risk

After reports of necrosis at the injection site after the 23-valent pneumococcal vaccine, an FDA investigation has concluded that the benefits of the vaccine outweigh the risks.

Sub-Q Ketamine for Severe Depression Safe, Highly Effective - Vimarsana News

Sub-Q Ketamine for Severe Depression Safe, Highly Effective

Subcutaneous ketamine is a practical, safe, and highly effective way to administer the drug for treatment-resistant depression, results of a randomized controlled phase 3 trial show.